IsofebrifugineCAS# 32434-44-9 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 32434-44-9 | SDF | Download SDF |
PubChem ID | 442914 | Appearance | Powder |
Formula | C16H19N3O3 | M.Wt | 301.3 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 3-[[(3aS,7aR)-2-hydroxy-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridin-2-yl]methyl]quinazolin-4-one | ||
SMILES | C1CC2C(CC(O2)(CN3C=NC4=CC=CC=C4C3=O)O)NC1 | ||
Standard InChIKey | YLYLCQRQSRDSQR-NNKZFNQJSA-N | ||
Standard InChI | InChI=1S/C16H19N3O3/c20-15-11-4-1-2-5-12(11)18-10-19(15)9-16(21)8-13-14(22-16)6-3-7-17-13/h1-2,4-5,10,13-14,17,21H,3,6-9H2/t13-,14+,16?/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Isofebrifugine shows antimalarial activity. |
Targets | Antifection |
Isofebrifugine Dilution Calculator
Isofebrifugine Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.319 mL | 16.5948 mL | 33.1895 mL | 66.379 mL | 82.9738 mL |
5 mM | 0.6638 mL | 3.319 mL | 6.6379 mL | 13.2758 mL | 16.5948 mL |
10 mM | 0.3319 mL | 1.6595 mL | 3.319 mL | 6.6379 mL | 8.2974 mL |
50 mM | 0.0664 mL | 0.3319 mL | 0.6638 mL | 1.3276 mL | 1.6595 mL |
100 mM | 0.0332 mL | 0.1659 mL | 0.3319 mL | 0.6638 mL | 0.8297 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Vitexin-4'-Rhamnoside(Rg)
Catalog No.:BCC8369
CAS No.:32426-34-9
- AKTide-2T
Catalog No.:BCC5908
CAS No.:324029-01-8
- Dexfenfluramine hydrochloride
Catalog No.:BCC5927
CAS No.:3239-45-0
- Imetit dihydrobromide
Catalog No.:BCC6768
CAS No.:32385-58-3
- Medicarpin
Catalog No.:BCN5241
CAS No.:32383-76-9
- 9,9-Bis(4-hydroxyphenyl)fluorene
Catalog No.:BCC8795
CAS No.:3236-71-3
- 4-Nitrobenzyl carbamate
Catalog No.:BCN3286
CAS No.:32339-07-4
- p-Cresyl sulfate
Catalog No.:BCC4013
CAS No.:3233-58-7
- SCS
Catalog No.:BCC7266
CAS No.:3232-36-8
- Triphosgene
Catalog No.:BCC2848
CAS No.:32315-10-9
- H-Threoninol
Catalog No.:BCC2705
CAS No.:3228-51-1
- 4-Methoxy-1-methylquinolin-2-one
Catalog No.:BCN4824
CAS No.:32262-18-3
- H-D-Cys-OH.H2O.HCl
Catalog No.:BCC2913
CAS No.:32443-99-5
- Khasianine
Catalog No.:BCN2530
CAS No.:32449-98-2
- 20(29)-Lupene-3,23-diol
Catalog No.:BCN5242
CAS No.:32451-85-7
- Isochlorogenic acid
Catalog No.:BCN5910
CAS No.:534-61-2
- NPS-2143 hydrochloride
Catalog No.:BCC1808
CAS No.:324523-20-8
- 1-Indanamine hydrochloride
Catalog No.:BCC8467
CAS No.:32457-23-1
- T 0156 hydrochloride
Catalog No.:BCC5803
CAS No.:324572-93-2
- Periplocymarin
Catalog No.:BCN8485
CAS No.:32476-67-8
- Myricanone
Catalog No.:BCN5243
CAS No.:32492-74-3
- Isorhapotogenin
Catalog No.:BCN3383
CAS No.:32507-66-7
- Ergosta-7,22-dien-3-one
Catalog No.:BCN7088
CAS No.:32507-77-0
- Sulfo-NHS-SS-Biotin
Catalog No.:BCC3580
CAS No.:325143-98-4
Combination effects of chloroquine with the febrifugine and isofebrifugine mixture against a blood-induced infection with chloroquine-resistant Plasmodium berghei NK65 in ICR mice.[Pubmed:14669265]
Phytother Res. 2003 Dec;17(10):1234-6.
The combination effects of chloroquine with a mixture of febrifugine and Isofebrifugine were evaluated against a blood-induced infection with chloroquine-resistant P. berghei NK65 in ICR mice. Mice in the untreated control showed a progressively increasing parasitemia leading to mouse death. A two-day dosage of 20 mg base/kg of chloroquine alone showed little effect against P. berghei NK65 infection, and all mice died from day 13 to 14 with an increasing parasitemia. A four-day dosage of 1 mg/kg of the febrifugine and Isofebrifugine mixture alone showed a little antimalarial activity, but all mice died from day 19 to 27 with an increasing parasitemia. On the other hand, mice treated with chloroquine plus alkaloids survived during the experiment. All mice treated with chloroquine alone or the alkaloid mixture alone showed low parasitemia levels during a drug administration and following a few days, but then malaria parasites increased in the bloodstream of the treated mice until death. On the other hand, malaria parasites in the mice given chloroquine plus alkaloids decreased on day 6 and then were not detected by a microscopic examination during observation period.